Sodium in PDB 6o4y: Structure of Hla-A2:01 with Peptide MM91
Protein crystallography data
The structure of Structure of Hla-A2:01 with Peptide MM91, PDB code: 6o4y
was solved by
G.Ying,
A.Bitra,
D.M.Zajonc,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
32.00 /
1.58
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
52.990,
80.861,
56.933,
90.00,
113.32,
90.00
|
R / Rfree (%)
|
17.9 /
20.5
|
Sodium Binding Sites:
The binding sites of Sodium atom in the Structure of Hla-A2:01 with Peptide MM91
(pdb code 6o4y). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 4 binding sites of Sodium where determined in the
Structure of Hla-A2:01 with Peptide MM91, PDB code: 6o4y:
Jump to Sodium binding site number:
1;
2;
3;
4;
Sodium binding site 1 out
of 4 in 6o4y
Go back to
Sodium Binding Sites List in 6o4y
Sodium binding site 1 out
of 4 in the Structure of Hla-A2:01 with Peptide MM91
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Structure of Hla-A2:01 with Peptide MM91 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na302
b:25.4
occ:1.00
|
O
|
A:ASP37
|
2.7
|
16.3
|
1.0
|
NA
|
A:NA303
|
2.8
|
21.9
|
1.0
|
N
|
A:GLN43
|
2.8
|
16.3
|
1.0
|
CA
|
A:GLN43
|
3.2
|
16.4
|
1.0
|
O
|
A:ALA40
|
3.3
|
18.3
|
1.0
|
CB
|
A:ALA40
|
3.4
|
20.3
|
1.0
|
C
|
A:ALA40
|
3.6
|
19.5
|
1.0
|
OG
|
A:SER42
|
3.6
|
19.0
|
1.0
|
NE2
|
A:GLN43
|
3.6
|
17.1
|
1.0
|
C
|
A:ASP37
|
3.8
|
15.9
|
1.0
|
CA
|
A:ALA40
|
3.8
|
19.9
|
1.0
|
N
|
A:ARG44
|
3.9
|
16.2
|
1.0
|
N
|
A:SER42
|
3.9
|
17.9
|
1.0
|
C
|
A:SER42
|
4.0
|
16.9
|
1.0
|
N
|
A:ALA40
|
4.0
|
20.6
|
1.0
|
C
|
A:GLN43
|
4.0
|
15.9
|
1.0
|
CD
|
A:GLN43
|
4.1
|
16.4
|
1.0
|
CE1
|
A:PHE36
|
4.2
|
15.2
|
1.0
|
N
|
A:ASP37
|
4.2
|
14.4
|
1.0
|
N
|
A:ALA41
|
4.3
|
19.7
|
1.0
|
CA
|
A:SER42
|
4.3
|
17.9
|
1.0
|
OE1
|
A:GLU46
|
4.4
|
24.6
|
1.0
|
O
|
A:ARG44
|
4.4
|
15.2
|
1.0
|
CB
|
A:GLN43
|
4.4
|
16.3
|
1.0
|
CG
|
A:GLN43
|
4.4
|
16.8
|
1.0
|
CZ
|
A:PHE36
|
4.5
|
15.7
|
1.0
|
CD1
|
A:PHE36
|
4.5
|
14.7
|
1.0
|
C
|
A:ALA41
|
4.5
|
18.9
|
1.0
|
CB
|
A:SER42
|
4.5
|
19.1
|
1.0
|
O
|
A:HOH539
|
4.6
|
24.7
|
1.0
|
CA
|
A:ASP37
|
4.6
|
15.6
|
1.0
|
N
|
A:SER38
|
4.8
|
15.7
|
1.0
|
OE1
|
A:GLN43
|
4.8
|
17.5
|
1.0
|
C
|
A:SER38
|
4.8
|
17.6
|
1.0
|
O
|
A:SER38
|
4.9
|
19.7
|
1.0
|
CA
|
A:SER38
|
5.0
|
16.5
|
1.0
|
|
Sodium binding site 2 out
of 4 in 6o4y
Go back to
Sodium Binding Sites List in 6o4y
Sodium binding site 2 out
of 4 in the Structure of Hla-A2:01 with Peptide MM91
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Structure of Hla-A2:01 with Peptide MM91 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na303
b:21.9
occ:1.00
|
OE1
|
A:GLU46
|
2.6
|
24.6
|
1.0
|
NA
|
A:NA302
|
2.8
|
25.4
|
1.0
|
O
|
A:ARG44
|
2.8
|
15.2
|
1.0
|
N
|
A:ASP37
|
3.2
|
14.4
|
1.0
|
OG
|
A:SER42
|
3.5
|
19.0
|
1.0
|
CA
|
A:PHE36
|
3.5
|
13.1
|
1.0
|
CD
|
A:GLU46
|
3.6
|
21.1
|
1.0
|
O
|
A:ASP37
|
3.8
|
16.3
|
1.0
|
CG
|
A:GLU46
|
3.8
|
18.6
|
1.0
|
C
|
A:PHE36
|
3.8
|
13.4
|
1.0
|
CD1
|
A:PHE36
|
3.9
|
14.7
|
1.0
|
C
|
A:ARG44
|
4.0
|
15.1
|
1.0
|
NH1
|
A:ARG35
|
4.1
|
22.6
|
1.0
|
O
|
A:ARG35
|
4.1
|
13.2
|
1.0
|
N
|
A:ARG44
|
4.2
|
16.2
|
1.0
|
CB
|
A:ALA40
|
4.2
|
20.3
|
1.0
|
CD
|
A:ARG35
|
4.2
|
19.2
|
1.0
|
CG
|
A:PHE36
|
4.2
|
14.5
|
1.0
|
CA
|
A:ASP37
|
4.3
|
15.6
|
1.0
|
CB
|
A:PHE36
|
4.4
|
14.0
|
1.0
|
CE1
|
A:PHE36
|
4.4
|
15.2
|
1.0
|
N
|
A:PHE36
|
4.4
|
12.7
|
1.0
|
C
|
A:ASP37
|
4.5
|
15.9
|
1.0
|
C
|
A:ARG35
|
4.6
|
13.2
|
1.0
|
O
|
A:HOH539
|
4.6
|
24.7
|
1.0
|
N
|
A:GLN43
|
4.7
|
16.3
|
1.0
|
CB
|
A:ASP37
|
4.7
|
17.3
|
1.0
|
OE2
|
A:GLU46
|
4.7
|
26.0
|
1.0
|
CA
|
A:ARG44
|
4.7
|
16.4
|
1.0
|
CZ
|
A:ARG35
|
4.8
|
22.1
|
1.0
|
NE
|
A:ARG35
|
4.8
|
20.8
|
1.0
|
CB
|
A:GLU46
|
4.8
|
16.4
|
1.0
|
CB
|
A:SER42
|
4.8
|
19.1
|
1.0
|
N
|
A:MET45
|
4.9
|
14.7
|
1.0
|
N
|
A:GLU46
|
4.9
|
14.5
|
1.0
|
CA
|
A:GLN43
|
5.0
|
16.4
|
1.0
|
C
|
A:GLN43
|
5.0
|
15.9
|
1.0
|
|
Sodium binding site 3 out
of 4 in 6o4y
Go back to
Sodium Binding Sites List in 6o4y
Sodium binding site 3 out
of 4 in the Structure of Hla-A2:01 with Peptide MM91
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Structure of Hla-A2:01 with Peptide MM91 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na304
b:23.7
occ:1.00
|
OE1
|
A:GLN96
|
2.6
|
14.6
|
1.0
|
N
|
A:GLY120
|
2.9
|
17.1
|
1.0
|
O
|
A:THR94
|
3.1
|
15.5
|
1.0
|
N
|
A:ASP119
|
3.2
|
15.8
|
1.0
|
O
|
A:ALA117
|
3.3
|
13.0
|
1.0
|
C
|
A:ALA117
|
3.5
|
13.0
|
1.0
|
CD
|
A:GLN96
|
3.5
|
13.9
|
1.0
|
C
|
A:TYR118
|
3.6
|
13.8
|
1.0
|
N
|
A:GLN96
|
3.7
|
12.6
|
1.0
|
C
|
A:THR94
|
3.7
|
16.0
|
1.0
|
N
|
A:TYR118
|
3.7
|
12.9
|
1.0
|
CB
|
A:ALA117
|
3.7
|
13.4
|
1.0
|
CA
|
A:GLY120
|
3.7
|
17.4
|
1.0
|
CA
|
A:TYR118
|
3.7
|
13.3
|
1.0
|
CG
|
A:GLN96
|
3.8
|
13.0
|
1.0
|
CG2
|
A:THR94
|
3.8
|
17.6
|
1.0
|
CA
|
A:ASP119
|
3.9
|
16.7
|
1.0
|
C
|
A:ASP119
|
3.9
|
17.0
|
1.0
|
C
|
A:VAL95
|
4.0
|
13.4
|
1.0
|
CB
|
A:GLN96
|
4.0
|
12.6
|
1.0
|
CA
|
A:VAL95
|
4.0
|
14.4
|
1.0
|
CB
|
A:THR94
|
4.1
|
17.4
|
1.0
|
NE2
|
B:HIS31
|
4.1
|
19.2
|
1.0
|
N
|
A:VAL95
|
4.1
|
14.9
|
1.0
|
CA
|
A:ALA117
|
4.2
|
13.1
|
1.0
|
CE1
|
B:HIS31
|
4.3
|
18.7
|
1.0
|
O
|
A:TYR118
|
4.3
|
14.3
|
1.0
|
CA
|
A:GLN96
|
4.5
|
12.3
|
1.0
|
CA
|
A:THR94
|
4.5
|
16.1
|
1.0
|
C
|
A:GLY120
|
4.7
|
17.6
|
1.0
|
N
|
A:LYS121
|
4.7
|
17.4
|
1.0
|
O
|
A:VAL95
|
4.8
|
13.7
|
1.0
|
NE2
|
A:GLN96
|
4.8
|
14.4
|
1.0
|
|
Sodium binding site 4 out
of 4 in 6o4y
Go back to
Sodium Binding Sites List in 6o4y
Sodium binding site 4 out
of 4 in the Structure of Hla-A2:01 with Peptide MM91
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 4 of Structure of Hla-A2:01 with Peptide MM91 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na305
b:20.2
occ:1.00
|
OD2
|
A:ASP77
|
2.7
|
13.4
|
1.0
|
NH2
|
A:ARG97
|
2.8
|
12.9
|
1.0
|
O
|
C:VAL7
|
2.8
|
13.4
|
1.0
|
O3
|
C:GOL101
|
3.4
|
13.8
|
1.0
|
CG2
|
A:THR73
|
3.5
|
12.8
|
1.0
|
CG
|
A:ASP77
|
3.6
|
12.5
|
1.0
|
CE2
|
A:TYR116
|
3.6
|
13.2
|
1.0
|
CZ
|
A:ARG97
|
3.7
|
13.1
|
1.0
|
NH1
|
A:ARG97
|
3.7
|
14.2
|
1.0
|
CZ2
|
A:TRP147
|
3.7
|
12.9
|
1.0
|
N
|
C:VAL9
|
3.7
|
13.8
|
1.0
|
CG1
|
C:VAL9
|
3.8
|
13.4
|
1.0
|
OD1
|
A:ASP77
|
3.8
|
13.0
|
1.0
|
CA
|
C:GLY8
|
3.8
|
13.5
|
1.0
|
C
|
C:VAL7
|
3.8
|
14.3
|
1.0
|
C
|
C:GLY8
|
3.9
|
13.4
|
1.0
|
CH2
|
A:TRP147
|
4.3
|
13.3
|
1.0
|
N
|
C:GLY8
|
4.3
|
14.3
|
1.0
|
OH
|
A:TYR116
|
4.3
|
14.7
|
1.0
|
CZ
|
A:TYR116
|
4.3
|
13.8
|
1.0
|
CD2
|
A:TYR116
|
4.4
|
13.0
|
1.0
|
C3
|
C:GOL101
|
4.6
|
14.6
|
1.0
|
CA
|
C:VAL9
|
4.6
|
13.5
|
1.0
|
CB
|
C:VAL9
|
4.7
|
13.3
|
1.0
|
O
|
C:GLY8
|
4.8
|
13.9
|
1.0
|
CE2
|
A:TRP147
|
4.8
|
13.8
|
1.0
|
NE
|
A:ARG97
|
4.9
|
12.8
|
1.0
|
CB
|
A:THR73
|
4.9
|
12.8
|
1.0
|
CB
|
A:ASP77
|
5.0
|
12.4
|
1.0
|
|
Reference:
M.Mishto,
A.Mansurkhodzhaev,
G.Ying,
A.Bitra,
R.A.Cordfunke,
S.Henze,
D.Paul,
J.Sidney,
H.Urlaub,
J.Neefjes,
A.Sette,
D.M.Zajonc,
J.Liepe.
Anin Silico-in Vitropipeline Identifying An Hla-A*02:01+Kras G12V+Spliced Epitope Candidate For A Broad Tumor-Immune Response in Cancer Patients. Front Immunol V. 10 2572 2019.
ISSN: ESSN 1664-3224
PubMed: 31803176
DOI: 10.3389/FIMMU.2019.02572
Page generated: Tue Oct 8 12:26:11 2024
|